Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Tristel ( (GB:TSTL) ) just unveiled an announcement.
Tristel plc, a UK-based infection prevention specialist, develops and manufactures chlorine dioxide-based disinfection products for the manual decontamination of medical devices and hospital surfaces. The company has a global footprint through multiple subsidiaries and aims for consistent revenue growth, high margins, and rising dividends for shareholders.
The company has disclosed that Artemis Investment Management LLP now holds 3.00216% of its issued share capital as of 16 April 2026. The stake notification highlights ongoing institutional interest in Tristel’s equity, underscoring its profile among professional investors on London’s AIM market.
The most recent analyst rating on (GB:TSTL) stock is a Hold with a £400.00 price target. To see the full list of analyst forecasts on Tristel stock, see the GB:TSTL Stock Forecast page.
Spark’s Take on TSTL Stock
According to Spark, TipRanks’ AI Analyst, TSTL is a Outperform.
The score is driven primarily by strong financial performance and a constructive earnings update with reiterated growth/margin targets and solid H1 results. Offsetting factors are weak near-term technical momentum (below key moving averages with negative MACD) and a relatively high P/E, partially balanced by the ~3.6% dividend yield.
To see Spark’s full report on TSTL stock, click here.
More about Tristel
Tristel plc is a global infection prevention company that manufactures and supplies products based on its proprietary chlorine dioxide chemistry. It is a market leader in the manual decontamination of medical devices and also offers a sporicidal surface disinfection range as a sustainable alternative to pre-wetted plastic wipes for hospitals and healthcare settings.
The company operates from its head office and manufacturing facility near Cambridge, employing around 270 staff across 16 subsidiaries and selling into more than 40 countries. Listed on London’s AIM market since 2005 under the ticker TSTL, Tristel targets double-digit annual revenue growth, an adjusted EBITDA margin of at least 25%, and progressive dividend increases supported by strong cash generation.
Average Trading Volume: 134,581
Technical Sentiment Signal: Strong Buy
Current Market Cap: £182.1M
See more data about TSTL stock on TipRanks’ Stock Analysis page.